Avant Genomics
Charlottesville, US · Founded 2023 · 11 employees on LinkedIn · 5 known investors
Avant Genomics is developing an automated platform for liquid biopsy sample preparation, using an enclosed fluidic cartridge and benchtop instruments that integrate DNA enrichment and purification for blood-based cancer detection. The system targets research labs, clinical testing environments, and reference laboratories aiming to reduce manual labor and cost in precision oncology workflows.
Founders & leadership
Avant Genomics was founded in 2023 by Rachelle and Renna.
Investors · 5
Also in the syndicate · 3
Funding
SEC filings, press & company announcements$3M disclosed across 1 of 2 rounds · 2026
- $3MraisedMay 2026 · 2 sources
CAV Angels, Global Impact Fund, Halyard Ventures, TitletownTech, Virginia Venture Partners
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Avant Genomics do?
- Avant Genomics is developing an automated platform for liquid biopsy sample preparation, using an enclosed fluidic cartridge and benchtop instruments that integrate DNA enrichment and purification for blood-based cancer detection. The system targets research labs, clinical testing environments, and reference laboratories aiming to reduce manual labor and cost in precision oncology workflows.
- Who founded Avant Genomics?
- Avant Genomics was founded by Rachelle, Renna in 2023.
- Who are Avant Genomics's investors?
- Avant Genomics's investors include TitletownTech, Virginia Venture Partners.
- How much funding has Avant Genomics raised?
- Avant Genomics has disclosed $3M raised across 1 of its 2 known rounds.
- Where is Avant Genomics headquartered?
- Avant Genomics is headquartered in Charlottesville, US.